In 2023, Italy led with 5.46K FTEs dedicated to internal R&D in human health, followed by Taiwan at 3.9K and Canada at 1.53K. Among major markets, South Korea exhibited substantial growth with a year-on-year increase of 16.6%, while Lithuania displayed a remarkable 27.78% increase. The United Kingdom and Poland also recorded robust growth rates of 4.4% and 4.62% respectively. Conversely, Hungary saw a decline of 3.36%. Over a five-year span, the compound annual growth rate highlights steady gains across countries, with emerging markets like Lithuania and South Korea showing significant upward trends.
Future Trends to Watch:
- Expect increased R&D personnel in countries with strong biotechnology and pharmaceutical sectors, driven by heightened demand for innovative healthcare solutions.
- Continual growth in emerging markets (e.g., Eastern Europe and Asia) as these regions invest in healthcare infrastructure and technology development.
- Digital transformation and growing emphasis on personalized medicine may spur further investments in specialized R&D roles.
Top countries in Total Internal R&D Personnel in Human Health Activities by Country
| # | 10 Countries | Units (Full-Time Equivalent) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 5,460 | 2023 | +4.32% | +3.1% | View data |
| 2 | 2 Taiwan | 3,900 | 2023 | +3.38% | +4.7% | View data |
| 3 | 3 Canada | 1,530 | 2023 | +0.92% | +4.43% | View data |
| 4 | 4 Spain | 1,480 | 2023 | +0.22% | +0.34% | View data |
| 5 | 5 United Kingdom | 720.6 | 2023 | +4.46% | +4.4% | View data |
| 6 | 6 South Korea | 626.78 | 2023 | +9.15% | +16.6% | View data |
| 7 | 7 Israel | 463 | 2023 | +1.76% | +1.87% | View data |
| 8 | 8 Poland | 445 | 2023 | +4.95% | +4.62% | View data |
| 9 | 9 New Zealand | 334 | 2023 | +10.23% | +8.61% | View data |
| 10 | 10 Hungary | 134 | 2023 | -7.59% | -3.36% | View data |
